Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce

To the Editor:

SARS-CoV-2 Variants among Symptomatic Health Workers.

Shown is the distribution of the B.1.1.7 (alpha), delta, and other SARS-CoV-2 variants according to vaccination status and month of diagnosis among health workers at University of California San Diego Health, March through July 2021. The number of workers indicates those who were symptomatic and had available variant data, and the number of positive tests indicates those that included data on variants.

In December 2020, the University of California San Diego Health (UCSDH) workforce experienced a dramatic increase in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.

Read more

Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study

  1. Julia Hippisley-Cox, professor of clinical epidemiology and general practice1,
  2. Martina Patone, statistician1,
  3. Xue W Mei, epidemiologist1,
  4. Defne Saatci, clinical research fellow1,
  5. Sharon Dixon, clinical research fellow1,
  6. Kamlesh Khunti, professor of primary care diabetes and vascular medicine2,
  7. Francesco Zaccardi, senior clinical research fellow2,
  8. Peter Watkinson, associate professor of intensive care medicine and consultant in intensive care medicine35,
  9. Manu Shankar-Hari, professor of critical care medicine4,
  10. James Doidge, senior statistician and honorary associate professor56,
  11. David A Harrison, head statistician and honorary professor
Read more

Driving the Disorder to Extinction With a Faulty Edition of the SARS-CoV-2 Virus

Researchers design and style new COVID-19 remedy that takes advantage of a faulty edition of the SARS-CoV-2 virus to generate the ailment-leading to version to extinction.

What if the COVID-19 virus could be applied versus itself? Scientists at Penn Point out have intended a proof-of-strategy therapeutic that could be in a position to do just that. The group designed a artificial defective SARS-CoV-2 virus that is innocuous but interferes with the real virus’ expansion, likely leading to the extinction of each the sickness-resulting in virus and the artificial virus.

“In our experiments, we display that the wild-form [disease-causing] SARS-CoV-2 virus

Read more